About the Psychedelic Society of India
MISSION AND HISTORY
The Psychedelic Society, along with other organisations and individuals listed below, are calling on the Indian government to reschedule Entheogens, a natural occuring compounds found in hundreds Plants, that has been called a ‘breakthrough’ treatment for mental health & Spiritual Growth.
Recent trials using psilocybin to treat depression and anxiety have returned staggering results, with 80% of patients reporting significantly improved wellbeing or life satisfaction for up to six months from just a single dose.
Psilocybin is currently a Schedule 1 substance. Schedule 1 substances are not authorised for medical use and can only be supplied, possessed or administered in exceptional circumstances under a special Home Office licence. This means psilocybin cannot be prescribed by doctors, and that conducting research with it is extremely time-consuming and expensive.
By rescheduling psilocybin from Schedule 1 to Schedule 2 or below, research would become faster and cheaper, and doctors would be able to start prescribing the substance when they see fit.
STAFF
ADMINISTRATION
SUPPORT STAFF
CENTER
PROGRAMMING
CLINICAL
DEPARTMENT
PAUL MATTHEWS
AARON SWARTZ
OLIVER PARKER
OWEN WRIGHT
PARKER LUDWIG
AARON SWARTZ
OLIVER PARKER
OWEN WRIGHT
PARKER LUDWIG
PAUL MATTHEWS
KATE STONE
STELLA RICCI
LYDIA DOYLE
OLIVER PARKER
OWEN WRIGHT
PARKER LUDWIG
PARKER LUDWIG
KATE STONE
AARON SWARTZ
OLIVER PARKER
OWEN WRIGHT
BOARD
JANE DOE
PRESIDENT
JOHN DOE
VICE PRESIDENT
JOHN DOE
TREASURER
JANE DOE